Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Operating Expenses: 2024

Historic Other Operating Expenses for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $5.3 million.

  • Day One Biopharmaceuticals' Other Operating Expenses rose 181.76% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2024, which is N/A change from last year.
  • As of FY2024, Day One Biopharmaceuticals' Other Operating Expenses stood at $5.3 million.
  • Day One Biopharmaceuticals' Other Operating Expenses' 5-year high stood at $5.3 million during FY2024, with a 5-year trough of $5.3 million in FY2024.
  • Moreover, its 1-year median value for Other Operating Expenses was $5.3 million (2024), whereas its average is $5.3 million.